BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet (Q37874391)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 May 2011
edit
Language Label Description Also known as
English
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
scientific article published on 11 May 2011

    Statements

    BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet (English)
    Franz Gruber
    Martin C Müller
    Thomas Ernst
    Nicholas C P Cross
    1208-1215

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit